May 31, 2018 · Kyle W. Anderson is the Project Leader for H/D exchange mass spectrometry (HDX-MS) for biopharmaceutical analysis at NIST. He is also an Associate Research Professor at the Institute for Bioscience and Biotechnology Research (IBBR), a joint institute of the University of Maryland and NIST.

Kyle Anderson is the Project Leader of HDX-MS for Biopharmaceutical Analysis at NIST. In addition to using hydrogen/deuterium exchange mass spectrometry (HDX-MS) to characterize the structural dynamics of biopharmaceuticals, he is active in developing and promoting adoption of state-of-the-art methods, instrumentation, and software for HDX-MS ...

Dr. Anderson is honored for developing novel improvements to the technique of hydrogen-deuterium mass spectrometry (HDX-MS) that facilitate studies of the complex folding and motion of proteins that make up many new pharmaceuticals.

Kyle W Anderson. National Institute of Standards and Technology ... Verified email at nist.gov - Homepage. Articles Cited by Public access. Title. Sort. ... KW Anderson, J Chen, M Wang, N Mast, IA Pikuleva, IV Turko. PLoS One 10 (5), e0126592, 2015. 66: 2015: Histone post-translational modifications in frontal cortex from human donors with ...

Sep 11, 2013 · NIST researchers developed an automated approach to study the structural dynamics of membrane proteins, the most common targets for pharmaceuticals. The method involves isolation of proteins from their phospholipid bilayer using a scheme that is compatible with robotic handling.

Feb 1, 2024 · NIST-IBBR scientist Kyle Anderson is the recipient of a 2023 U.S. Department of Commerce Bronze Medal. He is recognized for developing novel hydrogen-exchange mass-spectrometry methods that improve understanding of the structure and activity of …

Jan 22, 2025 · NIST-IBBR scientist Kyle Anderson was one of 400 federally funded early-career scientists to receive the Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. government on outstanding scientists and …

Kyle Anderson is a research chemist with National Institute of Standards and Technology (NIST) and located at Institute for Bioscience and Biotechnology Research (IBBR) in Rockville, MD. He earned his PhD in Biochemistry from University of Maryland College Park and conducted his doctoral research at NIST.

Kyle Anderson is the Project Leader of HDX-MS for Biopharmaceutical Analysis at the National Institute of Standards and Technology (NIST) and located at the Institute for Bioscience at Biotechnology Research (IBBR).